Showing 1 - 3 results of 3 for search 'Jacques Fantini', query time: 0.02s Refine Results
  1. 1
    Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53

    Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 by Jacques Fantini, Fodil Azzaz, Anaïs Aulas, Henri Chahinian, Nouara Yahi

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53

    Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 by Jacques Fantini, Fodil Azzaz, Anaïs Aulas, Henri Chahinian, Nouara Yahi

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    “Outlaw” mutations in quasispecies of SARS-CoV-2 inhibit replication

    “Outlaw” mutations in quasispecies of SARS-CoV-2 inhibit replication by Philippe Colson, Jacques Fantini, Jeremy Delerce, Wahiba Bader, Anthony Levasseur, Pierre Pontarotti, Christian Devaux, Didier Raoult

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: